Difference between revisions of "CT Coordinating Committee"
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
:* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees | :* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees | ||
::* [[CT Volumetry Biomarker Ctte]] | ::* [[CT Volumetry Biomarker Ctte]] | ||
+ | :::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]] | ||
::* [[Lung Density Biomarker Ctte]] | ::* [[Lung Density Biomarker Ctte]] | ||
Revision as of 18:04, 13 February 2017
- Chairs: Gregory Goldmacher, MD, PhD, MBA (Co-Chair), Lawrence Schwartz, MD (Co-chair), David Lynch, MD (Vice-chair)
- Secretary: Susan Weinmann (RSNA Staff)
- Roster: <link to roster of active attendees and who has voting privileges>
Scope
The CT Coordinating Committee coordinates Biomarker Committees based on CT.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact the secretary for details.
- CT CC Call Summaries